0001437749-20-025437.txt : 20201216 0001437749-20-025437.hdr.sgml : 20201216 20201216080120 ACCESSION NUMBER: 0001437749-20-025437 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20201216 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201216 DATE AS OF CHANGE: 20201216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 201391328 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 8-K 1 transe20201215_8k.htm FORM 8-K transe20201215_8k.htm
false 0000876378 0000876378 2020-12-16 2020-12-16
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
 
FORM 8-K
_________________
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
December 16, 2020
Date of Report (date of earliest event reported)
_________________
 
TransEnterix, Inc.
(Exact name of Registrant as specified in its charter)
_________________
 
Delaware
(State or other jurisdiction of
incorporation or organization)
  
0-19437
(Commission
File Number)
  
11-2962080
(I.R.S. Employer
Identification Number)
 
635 Davis Drive, Suite 300
Morrisville, North Carolina 27560
(Address of principal executive offices)
 
919-765-8400
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
_________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading symbol
  
Name of each exchange on which registered
Common Stock
$0.001 par value per share
  
TRXC
  
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       ☐
 
 
 
 
 
Item 8.01
Other Events.
 
On December 16, 2020, TransEnterix, Inc., a Delaware corporation, issued a press release to announce that it has received its registration certificate by Roszdravnadzor, the Russian medical device regulatory agency allowing for its sale and utilization throughout the Russian Federation.
 
A copy of the press release is filed herewith as Exhibit 99.1 and incorporated herein by reference.
 
 
Item 9.01
Financial Statements and Exhibits.
 
(d)
Exhibit
 
  Exhibit No.
Description                                                                                        
 
 
99.1
 
 
104
Cover Page Interactive Data File (formatted in inline XBRL)
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
TRANSENTERIX, INC.
Date: December 16, 2020
/s/ Shameze Rampertab
Shameze Rampertab
Executive Vice President and Chief Financial Officer
 
2
 EX-99.1 2 ex_217851.htm EXHIBIT 99.1 ex_217851.htm

 

 

Exhibit 99.1

 

TransEnterix Announces Approval of Senhance® Surgical System in Russian Federation

Approval allows for marketing and sale of Senhance Surgical System for digital laparoscopy

 

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--December 16, 2020-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Senhance® Surgical System has received its registration certificate by Roszdravnadzor, the Russian medical device regulatory agency allowing for its sale and utilization throughout the Russian Federation.

 

“Russian regulatory approval is an important milestone for TransEnterix, and this is an underserved market for robotic surgery,” said Anthony Fernando, President and Chief Executive Officer of TransEnterix. “Russia has rapidly developed expertise and adoption of minimally invasive surgery over the past 10 years, but robotic surgery remains extremely limited in the region due to high per-procedure costs and the success of laparoscopic approaches. Senhance helps address these adoption hurdles. We have worked with BOWA previously to launch four Senhance programs in the Commonwealth of Independent States (CIS) region, and look forward to partnering to leverage this recent success in entering the largest CIS market.”

 

TransEnterix has been partnering with BOWA-electronic GmbH & Co. KG (BOWA), based in Germany, to commercialize the Senhance Surgical System in the CIS region over the past three years. BOWA, together with it’s wholly-owned subsidiary OOO “BOWA Eurasia”, have an established commercial and support presence in this region . They are well equipped to drive medical device sales and provide aftersale support to hospitals in the CIS region, including Russia, for the Senhance and BOWA’s own complementary surgical device portfolio of products.

 

The Senhance Surgical System is the first and only digital laparoscopic platform designed to maintain laparoscopic minimally invasive surgery standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 mm microlaparoscopic instruments, eye-sensing camera control, and reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy. TransEnterix also recently launched the first machine vision system in robotic surgery in the US. This first-of-its-kind augmented intelligence capability is powered by the new Intelligent Surgical Unit™ on the Senhance Surgical System. Not all features are currently available in every market.

 

 
 

 

About TransEnterix

 

At TransEnterix, Inc., we are digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through a new category of care called Digital Laparoscopy. Digitizing the interface enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and allows us to address the current clinical, cognitive and economic shortcomings in surgery. The system features the first machine vision system for use in robotic surgery which is powered by the new Intelligent Surgical Unit™ (ISU™) that enables augmented intelligence in surgery. The Senhance Surgical System brings the benefits of Digital Laparoscopy to patients around the world while staying true to the principles of value-based healthcare. Learn more about Digital Laparoscopy with the Senhance Surgical System here: https://Senhance.com/. Now available for sale in the US, the EU, Japan, Russia, and select other countries. For a complete list of indications for use, please visit: https://www.transenterix.com/indications-for-use/.

 

About BOWA Medical

 

BOWA develops and produces high-specification medical-technology solutions, and since 1977 has continuously developed into a leading technological supplier of energy-based surgical systems. With its three cutting-edge production sites in Gomaringen, Germany, Poznan, Poland, and Ashburton, UK, the core of the company is in the heart of Europe. International branches and sales offices in the Middle East, Russia, Brazil, Kazakhstan, Ukraine and additional countries across Asia guarantee global support for their customers. To find out more about, visit at www.bowa-medical.com.

 

Forward-Looking Statements

 

This press release includes statements relating to the Senhance Surgical System and that TransEnterix has received its registration certificate by the Russian medical device regulatory agency allowing for the Senhance System’s sale and utilization throughout the Russian Federation. These statements and other statements regarding our future plans and goals constitute "forward looking statements'' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and includes whether the Senhance Surgical System will help address the high-procedure costs of minimally invasive surgery in Russia. For a discussion of the risks and uncertainties associated with TransEnterix's business, please review our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 16, 2020 and our other filings we make with the SEC. You are cautioned not to place undue reliance on these forward looking statements, which are based on our expectations as of the date of this press release and speak only as of the origination date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

 

Investor Contact:

Mark Klausner, +1 443-213-0501

invest@transenterix.com

or

Media Contact:

Terri Clevenger, +1 203-682-8297

terri.clevenger@icrinc.com

 

 
 EX-101.SCH 3 trxc-20201216.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 trxc-20201216_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 trxc-20201216_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, Address Line Two Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 trxc-20201216_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 transe20201215_8k_htm.xml IDEA: XBRL DOCUMENT 0000876378 2020-12-16 2020-12-16 false 0000876378 8-K 2020-12-16 TransEnterix, Inc. DE 0-19437 11-2962080 635 Davis Drive Suite 300 Morrisville NC 27560 919 765-8400 false false false false Common Stock TRXC NYSE false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document And Entity Information
Dec. 16, 2020
Document Information [Line Items]  
Entity, Registrant Name TransEnterix, Inc.
Document, Type 8-K
Document, Period End Date Dec. 16, 2020
Entity, Incorporation, State or Country Code DE
Entity, File Number 0-19437
Entity, Tax Identification Number 11-2962080
Entity, Address, Address Line One 635 Davis Drive
Entity, Address, Address Line Two Suite 300
Entity, Address, City or Town Morrisville
Entity, Address, State or Province NC
Entity, Address, Postal Zip Code 27560
City Area Code 919
Local Phone Number 765-8400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol TRXC
Security Exchange Name NYSE
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000876378
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 96 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.trxc.com/20201216/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports transe20201215_8k.htm ex_217851.htm trxc-20201216.xsd trxc-20201216_def.xml trxc-20201216_lab.xml trxc-20201216_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "transe20201215_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "trxc-20201216_def.xml" ] }, "inline": { "local": [ "transe20201215_8k.htm" ] }, "labelLink": { "local": [ "trxc-20201216_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "trxc-20201216_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "trxc-20201216.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 27, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "trxc", "nsuri": "http://www.trxc.com/20201216", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "transe20201215_8k.htm", "contextRef": "d20208K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.trxc.com/20201216/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "transe20201215_8k.htm", "contextRef": "d20208K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity, Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.trxc.com/20201216/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001437749-20-025437-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-20-025437-xbrl.zip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end